Navigation Links
Mylan Schedules Financial Results Conference Call and Live Webcast for the Second Quarter Fiscal 2008
Date:7/24/2008

PITTSBURGH, July 24 /PRNewswire-FirstCall/ -- Mylan Inc. (NYSE: MYL) announced today that it will host a conference call and live webcast on Wednesday, August 6, 2008, at 10:30 a.m. ET to provide a review of the second quarter ended June 30, 2008. The company will release its financial results before the market opens August 6.

The dial-in number to access the August 6 call is 877-741-4241 or 719-325-4787 for international callers. A replay, available for approximately seven days, will be available at 888-203-1112 or 719-457-0820 for international callers with access pass code 8142044.

To access a live webcast of the August 6 call, please log on to Mylan's Web site (http://www.mylan.com) at least 15 minutes before the event is to begin to register and download or install any necessary software. A replay of the webcast will be available on http://www.mylan.com for approximately seven days.

Mylan Inc., with operations in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest -- and highest quality -- product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. For more information about Mylan, visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Daniel E. Crookshank Joins Mylan as Vice President - Investor Relations
2. Mylan Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R) Tablets
3. Mylan Announces Final FDA Approval for Generic Version of Antidepressant Effexor(R)
4. Mylan Announces Tentative FDA Approval for Generic Version of Antihypertensive Avalide(R) Tablets
5. Mylan Wins Generic Prilosec(R) Patent Litigation
6. Mylan Inc., NATCO Pharma Ltd. To Collaborate on Worldwide Marketing and Distribution of Generic Copaxone(R)
7. Mylan Announces Final FDA Approval for Zaleplon Capsules
8. Mylan Inc. Acquires Central Eastern European Generics Businesses of Merck KGaA
9. Mylan Launches Paroxetine Hydrochloride Extended-Release Tablets
10. Mylan Schedules Financial Results Conference Call and Live Webcast for the First Quarter Fiscal 2008
11. Mylan Declares Quarterly Preferred Stock Dividend

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...ire/--ThediabetespopulationintheUnitedStateswillal...ngonthediseaseisprojectedtohit$336billion,upfrom$1...mberissueof DiabetesCare .TheNational ChangingDiab...missionedtheanalysisbyateamfromtheUniversityofChic...canslivingwithdiabeteswillrisefrom23.7millionin200...
(Date:11/26/2009)...motional rollercoaster, study finds , , ...fear factor meets the jubilant sports fan. , A ...hose who root for the winning team -- enjoy the gr...tch and victory was in doubt, producing feelings o...hanksgiving weekend as you,re glued to the TV set,...
(Date:11/26/2009)...unications announces a highly effective and unconv...ggling to make an economic recovery. , ...rs is the type of challenge that could send ailing... Dr. David Benton, business growth expert and auth...dash; The Rfactor Intensive . “Fear is on...
(Date:11/25/2009)...wswire-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasd...nvestoreventsinDecember: ,, ASHBriefing ,... Principalinvestigatorswilldiscussdatapresentation...ultiplemyeloma,asfeaturedatthe51stAmericanSocietyo...eans,LA.Theteleconferencewillbeginat9:00a.m.CT/10:...
(Date:11/25/2009)...swire-USNewswire/--AnarticlebyJanetWoodcock,M.D.,d...h,titled"ADifficultBalance-PainManagement,DrugSafe...EnglandJournalofMedicine. ,, (Logo: http://www....Inthearticle,WoodcockdiscussesFDAeffortstostrikeab...itandmanagingtherisksposedbyvariousanalgesics.Asex...
Breaking Medicine News(10 mins):Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...revalence of contagious skin infections, the threa...mpted The Soap and Detergent Association (SDA) to ...ng America a “C-minus”, a downgrade from 2004, whe...ident of Education. “It’s the places we’re at ever...
...ncer Institute (NCI) has announced a grant of $17 ... Georgetown University Medical Center.// The aim o...lternative tobacco products reduce health risks of...very systems, products which range from low nicoti...
...recent research, development of heart failure can ...perienced at attack by enhancing the levels of a p...whose level when increased above normal, helped in...enter for Translational Medicine at Jefferson Medi...
... in the brains of vertebrates and fruit fly denote...se these visual maps// that need to be wired prope...dult stage. A general notion is that visual maps a...in the journal Current Biology, Drs. P. Robin Hies...
...n is suspected as the cause of death in a 2-year-o...icials said the total tool from the spinach infect...ubbuck died on Wednesday at a hospital in Salt Lak...meone in the house made him a spinach smoothie," M...
...boy who died on Monday at a local hospital in Tulu...lu victim, Health Ministry officials confirmed yes...s bird flu information center told Reuters that th...infection and the human toll is steadily rising. S...
Other Medicine News:Health News:America’s Clean Hands Report Card - Can’t Rise Above ‘C’ L 2Health News:America’s Clean Hands Report Card - Can’t Rise Above ‘C’ L 3Health News:Georgetown University Heads Alternative Tobacco Project 2Health News:Georgetown University Heads Alternative Tobacco Project 3Health News:Protein Increase Decreases Risk of Heart Failure 2Health News:Protein Increase Decreases Risk of Heart Failure 3Health News:Fruit fly’s visual map based entirely on genetic inputs 2
(Date:11/25/2009).../PRNewswire-FirstCall/--HeartWareInternational,Inc...deroflessinvasive,miniaturizedcirculatorysupportte...rtfailure,todayannouncedthatitisscheduledtomakeani...thCareConferenceat8:00amESTonWednesday,December2,2...l,December1-2. ,, AlivewebcastoftheCompany,spre...
(Date:11/24/2009)...,, WHAT:RomHoubens,aBelgianmanthoughttohavebeen...yfullyconsciousandawakeduringthattimeandwasthesubj...sfeaturedinthesegmenttoillustratehowpeoplewithLock...ion. ,, WHEN:GoodMorningAmerica-- Tuesday,Novem... ,, WHO:RomHoubenswasanengineeringstudentin1986...
(Date:11/24/2009)...-FirstCall/--Vermillion,Inc.(VRML)(PinkSheets:VRML...ndDisclosureStatementtoday,November24,2009,withthe...e.AhearingtoconsiderapprovaloftheDisclosureStateme...ringontheconfirmationofthePlanscheduledforJanuary7...msinfull.ThePlanisexpected,ifapproved,toallowholde...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Neogen Reports 18 25 Increase in Net Income 12 25 Increase in Revenues 14253 1Neogen Reports 18 25 Increase in Net Income 12 25 Increase in Revenues 14253 2Neogen Reports 18 25 Increase in Net Income 12 25 Increase in Revenues 14253 3Neogen Reports 18 25 Increase in Net Income 12 25 Increase in Revenues 14253 4Neogen Reports 18 25 Increase in Net Income 12 25 Increase in Revenues 14253 5Neogen Reports 18 25 Increase in Net Income 12 25 Increase in Revenues 14253 6Farletuzumab Data Presented on Phase II Clinical Trial in First Relapsed Ovarian Cancer Subjects 5056 1Farletuzumab Data Presented on Phase II Clinical Trial in First Relapsed Ovarian Cancer Subjects 5056 2Farletuzumab Data Presented on Phase II Clinical Trial in First Relapsed Ovarian Cancer Subjects 5056 3Farletuzumab Data Presented on Phase II Clinical Trial in First Relapsed Ovarian Cancer Subjects 5056 4HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study 58249 1HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study 58249 2HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study 58249 3
...May 29 Perceptive Informatics, the industry,s lea... of PAREXEL International Corporation (Nasdaq: P...igned to help investigators apply the new 1.1 vers...id Tumors) in medical imaging-based oncology trial...ated in the RECIST Working Group, has incorporated...
...II clinical trial investigating the effectiveness ...ombination with an injectable H5N1 pandemic influe...tudy is fully funded by HHS - this is the second s...ith the HHS , , - Intercell,s VE Patch may reduc...1 pandemic influenza outbreak with only a single d...
Other Medicine Technology:Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials 2Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials 3Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials 4Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials 5Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS 2Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS 3
Thermal Seal, Clear
...roseal 'A' film is a quick and effective means to ...s. The compliant inner layer is designed to seal t...minimizes the risk of aerosol formation and cross-...for use with fewer than 96 wells, and a peel-away ...
OptiTape refill. 250 sheet roll.
PCR Film (adhesive)
Medicine Products: